Protein-Induced Pluripotent Stem Cells via QQ-Protein Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current induced pluripotent stem cell (iPSC) technology faces inefficiencies, time consumption, complexity, and quality issues due to low gene and protein delivery efficiencies, random stoichiometry, and high mutation rates, limiting its clinical applications.
Innovation Solution
A protein-induced pluripotent stem cell (piPSC) technology using bacterial expressed, recombinant reprogramming proteins with a QQ-protein delivery technique for targeted nuclear delivery, enabling near 100% conversion efficiency within one week, and a feeder-free culture condition for high-quality piPSC generation without colony picking or clonal expansion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If viral vectors or plasmid transfection are used for gene delivery, then reprogramming can be achieved, but delivery efficiency is low and the process is time-consuming
Solution Approach 1:
The patent replaces mechanical/gene-based delivery systems (viral vectors, plasmid transfection) with a protein-based reprogramming system. Recombinant reprogramming proteins are directly delivered into somatic cells using QQ-reagent, bypassing the need for gene expression and transcriptional activation steps, thereby significantly reducing reprogramming time while maintaining high efficiency
Solution Approach 2:
The patent performs preliminary action by pre-expressing reprogramming proteins in bacterial systems before delivery. The QQ-reagent is also pre-formulated with optimized composition for efficient protein delivery. This preliminary preparation enables direct protein transduction without requiring complex gene delivery and expression machinery in the target cells
2Manufacturing precision
If colony picking and clonal expansion are performed for ES cell expansion, then cell lines can be selected, but the process is time-consuming and mutation rates increase
Solution Approach 1:
The patent extracts and eliminates the colony picking and clonal expansion steps from the traditional ES cell expansion process. By using feeder-free culture conditions with optimized medium formulations, the system enables direct expansion of piPSC colonies without requiring manual selection and sub-cloning, thereby maintaining cell line purity while dramatically reducing expansion time and minimizing mutation accumulation
Solution Approach 2:
The patent implements self-service by designing a culture system where piPSC colonies automatically maintain their pluripotent state and can be directly expanded in feeder-free conditions. The optimized culture medium and feeder-free environment enable colonies to self-maintain and self-expand without requiring external intervention for selection and sub-cloning
3Reliability
If mouse feeder cells are used for ES cell culture, then cells receive nutrients and attachment support, but viral transmission risk increases
Solution Approach 1:
The patent extracts and removes mouse feeder cells from the culture system, replacing them with feeder-free culture conditions. The system uses optimized culture medium containing essential growth factors and supplements that provide all necessary nutrients and support functions previously supplied by feeder cells, thereby eliminating the viral transmission risk while maintaining cell culture health and pluripotency
Solution Approach 2:
The patent introduces an intermediary system consisting of feeder-free culture medium with optimized formulations. This medium acts as an intermediary that provides all necessary nutritional and supportive functions previously mediated by mouse feeder cells, including growth factors, attachment proteins, and metabolic supplements, thereby maintaining cell culture support without the harmful viral transmission risk
4Reliability
If multiple cycles of gene transfection are performed, then reprogramming efficiency improves, but operational complexity and costs increase
Solution Approach 1:
The patent replaces complex multi-cycle gene transfection systems with a simplified protein delivery system. Recombinant reprogramming proteins are delivered in a single step using QQ-reagent, eliminating the need for repeated transfection cycles, viral production, and gene expression regulation steps, thereby reducing operational complexity while maintaining high reprogramming efficiency
Solution Approach 2:
The patent performs preliminary action by pre-expressing and purifying reprogramming proteins in bacterial systems before delivery. This preliminary preparation consolidates multiple complex steps (gene cloning, viral vector production, transfection optimization) into a single protein delivery step, thereby simplifying the overall process while ensuring high reprogramming efficiency
Data Source
Figure 1
Figure 2A~2B
Figure 3
AI summary
A method of generating protein-induced pluripotent stem cells by delivering bacterially expressed reprogramming proteins into nuclei of starting somatic cells using the QQ-protein transduction technique, repeating several cell reprogramming cycles for creating reprogrammed protein-induced pluripotent stem cells, moving the reprogrammed cells into a feeder-free medium for expansion, and expanding and passaging the reprogrammed cells in a whole dish for generating homogeneous piPS cells. Also provided are the piPCS cells formed using this method and uses thereof.